Draper Asset Management, LLC Dexcom Inc Transaction History

Draper Asset Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 08, 2024	BUY	$114.22 - $140.1 $172,814 - $211,971	1,513 New	1,513 $209,000
Q2 2022 Aug 12, 2022	SELL	$67.99 - $132.89 $44,669 - $87,308	-657 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$94.08 - $130.2 $2,069 - $2,864	-22 Reduced 3.24%	657 $336,000
Q4 2021 Feb 14, 2022	SELL	$129.87 - $162.82 $102,467 - $128,464	-789 Reduced 53.75%	679 $365,000
Q3 2021 Nov 15, 2021	BUY	$106.71 - $143.18 $21,768 - $29,208	204 Added 16.14%	1,468 $803,000
Q2 2021 Aug 10, 2021	SELL	$80.99 - $107.93 $27,212 - $36,264	-336 Reduced 21.0%	1,264 $540,000
Q1 2021 May 17, 2021	BUY	$84.79 - $104.74 $17,636 - $21,785	208 Added 14.94%	1,600 $575,000
Q4 2020 Mar 03, 2021	BUY	$78.0 - $104.5 $108,576 - $145,464	1,392 New	1,392 $515,000

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Draper Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Draper Asset Management, LLC with notifications on news.